查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2032330

精準精神病學市場報告：按產品類型、檢體、生物標記類型、技術、應用、最終用戶和地區分類（2026-2034 年）

Precision Psychiatry Market Report by Product Type, Sample, Biomarker Type, Technology, Application, End User, and Region 2026-2034
出版日期: | 出版商: IMARC | 英文 142 Pages | 商品交期: 2-3個工作天內

價格

2025年，全球精準精神醫學市場規模達14.064億美元。展望未來，IMARC Group預測，到2034年，該市場規模將達到46.274億美元，2026年至2034年的複合年成長率（CAGR）為13.72%。市場成長的主要促進因素包括：精神疾病在公眾中的盛行率不斷上升、對個人化治療方案和介入措施的需求日益成長，以及基因檢測和數據分析技術的興起。

精準精神醫學是指一種在精神健康領域廣泛應用的創新醫療方法。它利用眾多先進技術和個人化醫療，為精神疾病患者提供更有針對性、更有效的治療。這種方法認知到，憂鬱症、焦慮症、躁鬱症和思覺失調症等精神疾病是複雜且多方面的疾病，受遺傳、環境和生活方式等多種因素的共同影響。其目標是根據個體的獨特特徵，包括基因組成、神經生物學標記和個人情況，量身定做多種干預措施。這使得臨床醫生能夠更深入地了解精神疾病的潛在機制，並據此制定個人化的治療方案。此外，它還能辨識可能與某些精神疾病易感性相關或影響特定藥物反應的特定基因變異。這些資訊有助於選擇更合適、更有針對性的治療方法，從而提高治療效果，同時最大限度地降低副作用風險。

精準精神醫學市場的發展趨勢

全球市場的主要驅動力是公眾中精神疾病盛行率的不斷上升。加之對個人化治療方案和介入措施的需求日益成長，精準精神醫學在個體中的應用也顯著增加。這是因為精準精神醫學與醫療保健領域個人化醫療的整體趨勢相契合。個人化醫療承認每個人都是獨一無二的，需要根據遺傳、神經生物學和環境因素進行量身定做的治療。這種個人化方法因其有望帶來更有效的治療和更好的療效，正獲得患者的支持和公眾的廣泛關注。此外，基因檢測、神經影像學和數據分析等技術的不斷進步也大大促進了精準精神病學的發展和應用，對市場產生了積極影響。同時，隨著人們對精準精神醫學興趣的日益濃厚，研究活動和資金投入也不斷增加。學術機構、研究組織和製藥公司都在加大研究投入，以更深入地了解精神疾病的生物學機制並開發標靶治療方法，這進一步推動了市場的發展。快速的都市化、個人意識的提高以及醫療基礎設施的持續發展等其他因素也對市場產生了積極影響。

目錄

第1章：序言

第2章：調查方法

  • 調查目的
  • 相關利益者
  • 數據來源
    • 主要訊息
    • 次要訊息
  • 市場估值
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章執行摘要

第4章：引言

第5章：精準精神醫學的全球市場

  • 市場概覽
  • 市場表現
  • 新冠疫情的影響
  • 市場預測

第6章 市場區隔：依產品類型分類

  • 產品
  • 服務

第7章 市場區隔：依檢體

  • 血液衍生的
  • 非血液來源
    • 主要部分
      • 唾液
      • 尿
      • 腦脊髓液（CSF）
      • 其他

第8章 市場區隔：依生物標記類型分類

  • 基因生物標記
  • 蛋白質生物標記

第9章 市場區隔：依技術分類

  • 順序
    • 主要部分
      • 下一代定序（NGS）
      • 桑格定序
  • 聚合酵素鏈鎖反應（PCR）
    • 主要部分
      • 即時聚合酵素鏈鎖反應（RT-PCR）
      • 數位聚合酵素鏈鎖反應（dPCR）
  • 微陣列
  • 免疫檢測
  • 液相層析法聯用（LC-MS）
  • 其他

第10章 市場區隔：依應用領域分類

  • 阿茲海默症
  • 帕金森氏症
  • 自閉症
  • 憂鬱症
  • 躁鬱症
  • 其他

第11章 市場區隔：依最終用戶分類

  • 醫院/診斷實驗室
  • 學術和研究機構
  • 其他

第12章 市場區隔：依地區分類

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第13章：促進、抑制與機遇

第14章：價值鏈分析

第15章：波特五力分析

第16章：價格分析

第17章 競爭格局

  • 市場結構
  • 大公司
  • 主要公司簡介
    • Altimate Healthcare
    • Alto Nanoscience
    • ATAI Life Sciences NV
    • Fulgent Genetics Inc.
    • Invitae Corporation
    • Myriad Genetics Inc.
    • Precision Psychiatric Services Inc.
    • Tempus Labs Inc.
Product Code: SR112026A13298

The global precision psychiatry market size reached USD 1,406.4 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 4,627.4 Million by 2034, exhibiting a growth rate (CAGR) of 13.72% during 2026-2034. The rising prevalence of mental health disorders among the masses, the growing need for personalized treatment plans and interventions and the advent of genetic testing, and data analytics represent some of the key factors driving the market.

Precision psychiatry refers to an innovative medical approach that is widely adopted for mental health care. It leverages numerous advanced technologies and personalized medicine to provide more targeted and effective treatments for individuals suffering from psychiatric disorders. It recognizes that mental illnesses, such as depression, anxiety, bipolar disorder, and schizophrenia, are complex and multifaceted conditions influenced by a combination of genetic, environmental, and lifestyle factors. It aims to tailor multiple interventions based on an individual's unique characteristics, including their genetic makeup, neurobiological markers, and personal circumstances. It allows clinicians to gain deeper insights into the underlying mechanisms of psychiatric disorders and develop personalized treatment plans accordingly. Besides this, it also identifies specific genetic variations that may contribute to the susceptibility to certain mental health conditions or influence the response to particular medications. This information allows for the selection of more appropriate and targeted treatment options, increasing the likelihood of positive outcomes while minimizing the potential for adverse effects.

PRECISION PSYCHIATRY MARKET TRENDS:

The global market is majorly driven by the rising prevalence of mental health disorders among the masses. Coupled with the growing need for personalized treatment plans and interventions, there has been a considerable increase in the adoption of precision psychiatry among individuals. Since precision psychiatry aligns with the broader trend toward personalized medicine across various medical fields. It recognizes that each individual is unique and requires tailored treatments based on their genetic, neurobiological, and environmental factors. This personalized approach resonates with patients, as it offers the prospect of more effective treatments and improved outcomes, which is gaining widespread prominence among the masses. Moreover, continual technological advancements, such as the advent of genetic testing, neuroimaging, and data analytics have significantly contributed to the development and implementation of precision psychiatry, further impacting the market favorably. Apart from this, the growing interest in precision psychiatry is accompanied by rising research activities and funding support. Academic institutions, research organizations, and pharmaceutical companies are investing in research to better understand the biological mechanisms of psychiatric disorders and develop targeted treatments, hence providing an impetus to the market. Other factors, including rapid urbanization, growing awareness among individuals and continual developments in the healthcare infrastructure, are also positively influencing the market.

KEY MARKET SEGMENTATION:

Product Type Insights:

  • Products
  • Services

Sample Insights:

  • Blood-Based
  • Non-Blood-Based
    • Saliva
    • Urine
    • Cerebral Spinal Fluid (CSF)
    • Others

Biomarker Type Insights:

  • Genetic Biomarker
  • Protein Biomarker

Technology Insights:

  • Sequencing
    • Next-Generation Sequencing (NGS)
    • Sanger Sequencing
  • Polymerase Chain Reaction (PCR)
    • Real-Time Polymerase Chain Reaction (RT-PCR)
    • Digital Polymerase Chain Reaction (dPCR)
  • Microarray
  • Immunoassay
  • Liquid Chromatography-Mass Spectrometry (LC-MS)

Application Insights:

  • Alzheimer's Disease
  • Parkinson's Disease
  • Autism
  • Depression
  • Bipolar Disease

End User Insights:

  • Hospitals and Diagnostic Laboratories
  • Academic and Research Institutions

Regional Insights:

  • North America
    • United States
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for precision psychiatry. Some of the factors driving the North America precision psychiatry market included the growing awareness among the masses, the emerging healthcare industry, the shifting lifestyle preferences of the masses, etc.

COMPETITIVE LANDSCAPE:

The report has also provided a comprehensive analysis of the competitive landscape in the global precision psychiatry market. Detailed profiles of all major companies have been provided. Some of the companies covered include Altimate Healthcare, Alto Nanoscience, ATAI Life Sciences N.V., Fulgent Genetics Inc, Invitae Corporation, Myriad Genetics Inc., Precision Psychiatric Services Inc., Tempus Labs Inc., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Precision Psychiatry Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product Type

  • 6.1 Products
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Services
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Sample

  • 7.1 Blood-Based
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Non-Blood-Based
    • 7.2.1 Market Trends
    • 7.2.2 Key Segments
      • 7.2.2.1 Saliva
      • 7.2.2.2 Urine
      • 7.2.2.3 Cerebral Spinal Fluid (CSF)
      • 7.2.2.4 Others
    • 7.2.3 Market Forecast

8 Market Breakup by Biomarker Type

  • 8.1 Genetic Biomarker
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Protein Biomarker
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by Technology

  • 9.1 Sequencing
    • 9.1.1 Market Trends
    • 9.2.2 Key Segments
      • 9.2.2.1 Next-Generation Sequencing (NGS)
      • 9.2.2.2 Sanger Sequencing
    • 9.1.3 Market Forecast
  • 9.2 Polymerase Chain Reaction (PCR)
    • 9.2.1 Market Trends
    • 9.2.2 Key Segments
      • 9.2.2.1 Real-Time Polymerase Chain Reaction (RT-PCR)
      • 9.2.2.2 Digital Polymerase Chain Reaction (dPCR)
    • 9.2.3 Market Forecast
  • 9.3 Microarray
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Immunoassay
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast
  • 9.5 Liquid Chromatography-Mass Spectrometry (LC-MS)
    • 9.5.1 Market Trends
    • 9.5.2 Market Forecast
  • 9.6 Others
    • 9.6.1 Market Trends
    • 9.6.2 Market Forecast

10 Market Breakup by Application

  • 10.1 Alzheimer's Disease
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Parkinson's Disease
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 Autism
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast
  • 10.4 Depression
    • 10.4.1 Market Trends
    • 10.4.2 Market Forecast
  • 10.5 Bipolar Disease
    • 10.5.1 Market Trends
    • 10.5.2 Market Forecast
  • 10.6 Others
    • 10.6.1 Market Trends
    • 10.6.2 Market Forecast

11 Market Breakup by End User

  • 11.1 Hospitals and Diagnostic Laboratories
    • 11.1.1 Market Trends
    • 11.1.2 Market Forecast
  • 11.2 Academic and Research Institutions
    • 11.2.1 Market Trends
    • 11.2.2 Market Forecast
  • 11.3 Others
    • 11.3.1 Market Trends
    • 11.3.2 Market Forecast

12 Market Breakup by Region

  • 12.1 North America
    • 12.1.1 United States
      • 12.1.1.1 Market Trends
      • 12.1.1.2 Market Forecast
    • 12.1.2 Canada
      • 12.1.2.1 Market Trends
      • 12.1.2.2 Market Forecast
  • 12.2 Asia-Pacific
    • 12.2.1 China
      • 12.2.1.1 Market Trends
      • 12.2.1.2 Market Forecast
    • 12.2.2 Japan
      • 12.2.2.1 Market Trends
      • 12.2.2.2 Market Forecast
    • 12.2.3 India
      • 12.2.3.1 Market Trends
      • 12.2.3.2 Market Forecast
    • 12.2.4 South Korea
      • 12.2.4.1 Market Trends
      • 12.2.4.2 Market Forecast
    • 12.2.5 Australia
      • 12.2.5.1 Market Trends
      • 12.2.5.2 Market Forecast
    • 12.2.6 Indonesia
      • 12.2.6.1 Market Trends
      • 12.2.6.2 Market Forecast
    • 12.2.7 Others
      • 12.2.7.1 Market Trends
      • 12.2.7.2 Market Forecast
  • 12.3 Europe
    • 12.3.1 Germany
      • 12.3.1.1 Market Trends
      • 12.3.1.2 Market Forecast
    • 12.3.2 France
      • 12.3.2.1 Market Trends
      • 12.3.2.2 Market Forecast
    • 12.3.3 United Kingdom
      • 12.3.3.1 Market Trends
      • 12.3.3.2 Market Forecast
    • 12.3.4 Italy
      • 12.3.4.1 Market Trends
      • 12.3.4.2 Market Forecast
    • 12.3.5 Spain
      • 12.3.5.1 Market Trends
      • 12.3.5.2 Market Forecast
    • 12.3.6 Russia
      • 12.3.6.1 Market Trends
      • 12.3.6.2 Market Forecast
    • 12.3.7 Others
      • 12.3.7.1 Market Trends
      • 12.3.7.2 Market Forecast
  • 12.4 Latin America
    • 12.4.1 Brazil
      • 12.4.1.1 Market Trends
      • 12.4.1.2 Market Forecast
    • 12.4.2 Mexico
      • 12.4.2.1 Market Trends
      • 12.4.2.2 Market Forecast
    • 12.4.3 Others
      • 12.4.3.1 Market Trends
      • 12.4.3.2 Market Forecast
  • 12.5 Middle East and Africa
    • 12.5.1 Market Trends
    • 12.5.2 Market Breakup by Country
    • 12.5.3 Market Forecast

13 Drivers, Restraints, and Opportunities

  • 13.1 Overview
  • 13.2 Drivers
  • 13.3 Restraints
  • 13.4 Opportunities

14 Value Chain Analysis

15 Porters Five Forces Analysis

  • 15.1 Overview
  • 15.2 Bargaining Power of Buyers
  • 15.3 Bargaining Power of Suppliers
  • 15.4 Degree of Competition
  • 15.5 Threat of New Entrants
  • 15.6 Threat of Substitutes

16 Price Analysis

17 Competitive Landscape

  • 17.1 Market Structure
  • 17.2 Key Players
  • 17.3 Profiles of Key Players
    • 17.3.1 Altimate Healthcare
      • 17.3.1.1 Company Overview
      • 17.3.1.2 Product Portfolio
    • 17.3.2 Alto Nanoscience
      • 17.3.2.1 Company Overview
      • 17.3.2.2 Product Portfolio
    • 17.3.3 ATAI Life Sciences N.V.
      • 17.3.3.1 Company Overview
      • 17.3.3.2 Product Portfolio
    • 17.3.4 Fulgent Genetics Inc.
      • 17.3.4.1 Company Overview
      • 17.3.4.2 Product Portfolio
    • 17.3.5 Invitae Corporation
      • 17.3.5.1 Company Overview
      • 17.3.5.2 Product Portfolio
    • 17.3.6 Myriad Genetics Inc.
      • 17.3.6.1 Company Overview
      • 17.3.6.2 Product Portfolio
    • 17.3.7 Precision Psychiatric Services Inc.
      • 17.3.7.1 Company Overview
      • 17.3.7.2 Product Portfolio
    • 17.3.8 Tempus Labs Inc.
      • 17.3.8.1 Company Overview
      • 17.3.8.2 Product Portfolio

List of Figures

  • Figure 1: Global: Precision Psychiatry Market: Major Drivers and Challenges
  • Figure 2: Global: Precision Psychiatry Market: Sales Value (in Million USD), 2020-2025
  • Figure 3: Global: Precision Psychiatry Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 4: Global: Precision Psychiatry Market: Breakup by Product Type (in %), 2025
  • Figure 5: Global: Precision Psychiatry Market: Breakup by Sample (in %), 2025
  • Figure 6: Global: Precision Psychiatry Market: Breakup by Biomarker Type (in %), 2025
  • Figure 7: Global: Precision Psychiatry Market: Breakup by Technology (in %), 2025
  • Figure 8: Global: Precision Psychiatry Market: Breakup by Application (in %), 2025
  • Figure 9: Global: Precision Psychiatry Market: Breakup by End User (in %), 2025
  • Figure 10: Global: Precision Psychiatry Market: Breakup by Region (in %), 2025
  • Figure 11: Global: Precision Psychiatry (Products) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 12: Global: Precision Psychiatry (Products) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 13: Global: Precision Psychiatry (Services) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 14: Global: Precision Psychiatry (Services) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 15: Global: Precision Psychiatry (Blood-Based) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 16: Global: Precision Psychiatry (Blood-Based) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 17: Global: Precision Psychiatry (Non-Blood-Based) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 18: Global: Precision Psychiatry (Non-Blood-Based) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 19: Global: Precision Psychiatry (Genetic Biomarker) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 20: Global: Precision Psychiatry (Genetic Biomarker) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 21: Global: Precision Psychiatry (Protein Biomarker) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 22: Global: Precision Psychiatry (Protein Biomarker) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 23: Global: Precision Psychiatry (Sequencing) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 24: Global: Precision Psychiatry (Sequencing) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 25: Global: Precision Psychiatry (Polymerase Chain Reaction (PCR)) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 26: Global: Precision Psychiatry (Polymerase Chain Reaction (PCR)) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 27: Global: Precision Psychiatry (Microarray) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 28: Global: Precision Psychiatry (Microarray) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 29: Global: Precision Psychiatry (Immunoassay) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 30: Global: Precision Psychiatry (Immunoassay) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 31: Global: Precision Psychiatry (Liquid Chromatography-Mass Spectrometry (LC-MS)) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 32: Global: Precision Psychiatry (Liquid Chromatography-Mass Spectrometry (LC-MS)) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 33: Global: Precision Psychiatry (Other Technologies) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 34: Global: Precision Psychiatry (Other Technologies) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 35: Global: Precision Psychiatry (Alzheimer's Disease) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 36: Global: Precision Psychiatry (Alzheimer's Disease) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 37: Global: Precision Psychiatry (Parkinson's Disease) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 38: Global: Precision Psychiatry (Parkinson's Disease) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 39: Global: Precision Psychiatry (Autism) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 40: Global: Precision Psychiatry (Autism) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 41: Global: Precision Psychiatry (Depression) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 42: Global: Precision Psychiatry (Depression) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 43: Global: Precision Psychiatry (Bipolar Disease) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 44: Global: Precision Psychiatry (Bipolar Disease) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 45: Global: Precision Psychiatry (Other Applications) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 46: Global: Precision Psychiatry (Other Applications) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 47: Global: Precision Psychiatry (Hospitals and Diagnostic Laboratories) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 48: Global: Precision Psychiatry (Hospitals and Diagnostic Laboratories) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 49: Global: Precision Psychiatry (Academic and Research Institutions) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 50: Global: Precision Psychiatry (Academic and Research Institutions) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 51: Global: Precision Psychiatry (Other End Users) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 52: Global: Precision Psychiatry (Other End Users) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 53: North America: Precision Psychiatry Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 54: North America: Precision Psychiatry Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 55: United States: Precision Psychiatry Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 56: United States: Precision Psychiatry Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 57: Canada: Precision Psychiatry Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 58: Canada: Precision Psychiatry Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 59: Asia-Pacific: Precision Psychiatry Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 60: Asia-Pacific: Precision Psychiatry Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 61: China: Precision Psychiatry Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 62: China: Precision Psychiatry Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 63: Japan: Precision Psychiatry Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 64: Japan: Precision Psychiatry Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 65: India: Precision Psychiatry Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 66: India: Precision Psychiatry Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 67: South Korea: Precision Psychiatry Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 68: South Korea: Precision Psychiatry Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 69: Australia: Precision Psychiatry Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 70: Australia: Precision Psychiatry Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 71: Indonesia: Precision Psychiatry Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 72: Indonesia: Precision Psychiatry Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 73: Others: Precision Psychiatry Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 74: Others: Precision Psychiatry Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 75: Europe: Precision Psychiatry Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 76: Europe: Precision Psychiatry Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 77: Germany: Precision Psychiatry Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 78: Germany: Precision Psychiatry Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 79: France: Precision Psychiatry Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 80: France: Precision Psychiatry Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 81: United Kingdom: Precision Psychiatry Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 82: United Kingdom: Precision Psychiatry Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 83: Italy: Precision Psychiatry Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 84: Italy: Precision Psychiatry Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 85: Spain: Precision Psychiatry Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 86: Spain: Precision Psychiatry Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 87: Russia: Precision Psychiatry Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 88: Russia: Precision Psychiatry Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 89: Others: Precision Psychiatry Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 90: Others: Precision Psychiatry Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 91: Latin America: Precision Psychiatry Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 92: Latin America: Precision Psychiatry Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 93: Brazil: Precision Psychiatry Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 94: Brazil: Precision Psychiatry Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 95: Mexico: Precision Psychiatry Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 96: Mexico: Precision Psychiatry Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 97: Others: Precision Psychiatry Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 98: Others: Precision Psychiatry Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 99: Middle East and Africa: Precision Psychiatry Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 100: Middle East and Africa: Precision Psychiatry Market: Breakup by Country (in %), 2025
  • Figure 101: Middle East and Africa: Precision Psychiatry Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 102: Global: Precision Psychiatry Industry: Drivers, Restraints, and Opportunities
  • Figure 103: Global: Precision Psychiatry Industry: Value Chain Analysis
  • Figure 104: Global: Precision Psychiatry Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Precision Psychiatry Market: Key Industry Highlights, 2025 & 2034
  • Table 2: Global: Precision Psychiatry Market Forecast: Breakup by Product Type (in Million USD), 2026-2034
  • Table 3: Global: Precision Psychiatry Market Forecast: Breakup by Sample (in Million USD), 2026-2034
  • Table 4: Global: Precision Psychiatry Market Forecast: Breakup by Biomarker Type (in Million USD), 2026-2034
  • Table 5: Global: Precision Psychiatry Market Forecast: Breakup by Technology (in Million USD), 2026-2034
  • Table 6: Global: Precision Psychiatry Market Forecast: Breakup by Application (in Million USD), 2026-2034
  • Table 7: Global: Precision Psychiatry Market Forecast: Breakup by End User (in Million USD), 2026-2034
  • Table 8: Global: Precision Psychiatry Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 9: Global: Precision Psychiatry Market: Competitive Structure
  • Table 10: Global: Precision Psychiatry Market: Key Players